Fc 抗体
| Empty Table Header | 製品名 | CATALOG # | アイソタイプ | エピトープ | アプリケーション | Species | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|---|
Fc ε RIα 抗体 (X-22) | sc-100279 | mouse IgG1 κ | 1-258 (h) | WB, IP, ELISA | h | 2 | ||
Fc ε RIα 抗体 (1F2A9) | sc-517280 | mouse IgG1 κ | 42-103 (h) | WB, IF, IHC(P), FCM, ELISA | h | new | ||
Fc ε RIβ 抗体 (5-RE9) | sc-134340 | mouse IgG2a κ | 1-60 (h) | WB, IP, ELISA | h | new | ||
Fc ε RIβ 抗体 (F-1) | sc-393789 | mouse IgG2b κ | 1-21 (m) | WB, IP, IF, ELISA | m, r | 2 | ||
Fc ε RIβ 抗体 (H-5) | sc-398863 | mouse IgG2b κ | 111-235 (m) | WB, IP, IF, ELISA | m, r, h | 4 | ||
Fc ε RIγ 抗体 (E-12) | sc-390222 | mouse IgG2a κ | FL (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 6 | ||
Fc ε RIγ 抗体 (A-5) | sc-374335 | mouse IgG2a κ | 51-85 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
Fc ε RIγ 抗体 (F-1) | sc-390221 | mouse IgG1 κ | FL (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | new | ||
Fc ε RIγ 抗体 (G-3) | sc-390246 | mouse IgM κ | FL (h) | WB, IP, IF, ELISA | m, r, h | new | ||
Fc ε RIγ 抗体 (H-5) | sc-374385 | mouse IgG1 κ | 51-85 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
Fc γ RIIb 抗体 (RR05) | sc-73817 | rat IgG2a | 40-217 (m) | WB, IP (non-reducing), ELISA | m, r, h | new |
Fc CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
Fc ε RIα CRISPR/Cas9 KOプラスミド (h) | sc-416948 | h | Gene Knockout | GFP | 0 | ||
Fc ε RIα HDRプラスミド (h) | sc-416948-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Fc ε RIα Double Nickaseプラスミド (h) | sc-416948-NIC | h | Gene Knockout | Puromycin | 0 | ||
Fc ε RIα Double Nickaseプラスミド (h2) | sc-416948-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Fc ε RIα CRISPR/Cas9 KOプラスミド (m) | sc-420301 | m | Gene Knockout | GFP | 0 | ||
Fc ε RIα HDRプラスミド (m) | sc-420301-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Fc ε RIα Double Nickaseプラスミド (m) | sc-420301-NIC | m | Gene Knockout | Puromycin | 0 | ||
Fc ε RIα Double Nickaseプラスミド (m2) | sc-420301-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
Fc ε RIβ CRISPR/Cas9 KOプラスミド (h) | sc-418526 | h | Gene Knockout | GFP | 0 | ||
Fc ε RIβ HDRプラスミド (h) | sc-418526-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Fc ε RIβ Double Nickaseプラスミド (h) | sc-418526-NIC | h | Gene Knockout | Puromycin | 0 | ||
Fc ε RIβ Double Nickaseプラスミド (h2) | sc-418526-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Fc ε RIβ CRISPR/Cas9 KOプラスミド (m) | sc-420302 | m | Gene Knockout | GFP | 0 | ||
Fc ε RIβ HDRプラスミド (m) | sc-420302-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Fc ε RIβ Double Nickaseプラスミド (m) | sc-420302-NIC | m | Gene Knockout | Puromycin | 0 | ||
Fc ε RIβ Double Nickaseプラスミド (m2) | sc-420302-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
Fc ε RIγ CRISPR/Cas9 KOプラスミド (h) | sc-417621 | h | Gene Knockout | GFP | 0 | ||
Fc ε RIγ HDRプラスミド (h) | sc-417621-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Fc ε RIγ Double Nickaseプラスミド (h) | sc-417621-NIC | h | Gene Knockout | Puromycin | 0 | ||
Fc ε RIγ Double Nickaseプラスミド (h2) | sc-417621-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Fc ε RIγ CRISPR/Cas9 KOプラスミド (m) | sc-420303 | m | Gene Knockout | GFP | 0 | ||
Fc ε RIγ Double Nickaseプラスミド (m) | sc-420303-NIC | m | Gene Knockout | Puromycin | 0 | ||
Fc ε RIγ Double Nickaseプラスミド (m2) | sc-420303-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
Fc γ RIII CRISPR/Cas9 KOプラスミド (m) | sc-420307 | m | Gene Knockout | GFP | 0 | ||
Fc γ RIII HDRプラスミド (m) | sc-420307-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Fc γ RIII Double Nickaseプラスミド (m) | sc-420307-NIC | m | Gene Knockout | Puromycin | 0 | ||
Fc γ RIII Double Nickaseプラスミド (m2) | sc-420307-NIC-2 | m | Gene Knockout | Puromycin | 0 |
Fc CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
Fc ε RIα CRISPR Activationプラスミド (h) | sc-416948-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIα CRISPR Activationプラスミド (h2) | sc-416948-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIα Lentiviral Activation Particles (h) | sc-416948-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIα Lentiviral Activation Particles (h2) | sc-416948-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIα CRISPR Activationプラスミド (m) | sc-420301-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIα CRISPR Activationプラスミド (m2) | sc-420301-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIα Lentiviral Activation Particles (m) | sc-420301-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIα Lentiviral Activation Particles (m2) | sc-420301-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIβ CRISPR Activationプラスミド (h) | sc-418526-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIβ CRISPR Activationプラスミド (h2) | sc-418526-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIβ Lentiviral Activation Particles (h) | sc-418526-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIβ Lentiviral Activation Particles (h2) | sc-418526-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIβ CRISPR Activationプラスミド (m) | sc-420302-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIβ CRISPR Activationプラスミド (m2) | sc-420302-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIβ Lentiviral Activation Particles (m) | sc-420302-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIβ Lentiviral Activation Particles (m2) | sc-420302-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIγ CRISPR Activationプラスミド (h) | sc-417621-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIγ CRISPR Activationプラスミド (h2) | sc-417621-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIγ Lentiviral Activation Particles (h) | sc-417621-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIγ Lentiviral Activation Particles (h2) | sc-417621-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIγ CRISPR Activationプラスミド (m) | sc-420303-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIγ CRISPR Activationプラスミド (m2) | sc-420303-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIγ Lentiviral Activation Particles (m) | sc-420303-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc ε RIγ Lentiviral Activation Particles (m2) | sc-420303-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc γ RIII CRISPR Activationプラスミド (m) | sc-420307-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc γ RIII CRISPR Activationプラスミド (m2) | sc-420307-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc γ RIII Lentiviral Activation Particles (m) | sc-420307-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fc γ RIII Lentiviral Activation Particles (m2) | sc-420307-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |
Fc siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
Fc &epsilon RIβ shRNA プラスミド (h) | sc-45264-SH | h | Gene Silencing | Puromycin | 0 | ||
Fc &epsilon RIβ shRNA (h) レンチウイルス粒子 | sc-45264-V | h | Gene Silencing | Puromycin | 0 | ||
Fc &epsilon RIβ shRNA プラスミド (m) | sc-45265-SH | m | Gene Silencing | Puromycin | 0 | ||
Fc &epsilon RIβ shRNA (m) レンチウイルス粒子 | sc-45265-V | m | Gene Silencing | Puromycin | 0 | ||
Fc ε RIα siRNA (h) | sc-45258 | h | Gene Silencing | N/A | 0 | ||
Fc ε RIα shRNA プラスミド (h) | sc-45258-SH | h | Gene Silencing | Puromycin | 0 | ||
Fc ε RIα shRNA (h) レンチウイルス粒子 | sc-45258-V | h | Gene Silencing | Puromycin | 0 | ||
Fc ε RIα siRNA (m) | sc-45259 | m | Gene Silencing | N/A | 0 | ||
Fc ε RIα shRNA プラスミド (m) | sc-45259-SH | m | Gene Silencing | Puromycin | 0 | ||
Fc ε RIα shRNA (m) レンチウイルス粒子 | sc-45259-V | m | Gene Silencing | Puromycin | 0 | ||
Fc ε RIα siRNA (r) | sc-270639 | r | Gene Silencing | N/A | 0 | ||
Fc ε RIα shRNA プラスミド (r) | sc-270639-SH | r | Gene Silencing | N/A | 0 | ||
Fc ε RIα shRNA (r) レンチウイルス粒子 | sc-270639-V | r | Gene Silencing | N/A | 0 | ||
Fc ε RIβ siRNA (h) | sc-45264 | h | Gene Silencing | N/A | 0 | ||
Fc ε RIβ siRNA (m) | sc-45265 | m | Gene Silencing | N/A | 0 | ||
Fc ε RIγ siRNA (h) | sc-45267 | h | Gene Silencing | N/A | 0 | ||
Fc ε RIγ shRNA プラスミド (h) | sc-45267-SH | h | Gene Silencing | Puromycin | 0 | ||
Fc ε RIγ shRNA (h) レンチウイルス粒子 | sc-45267-V | h | Gene Silencing | Puromycin | 0 | ||
Fc ε RIγ siRNA (m) | sc-45268 | m | Gene Silencing | N/A | 0 | ||
Fc ε RIγ shRNA プラスミド (m) | sc-45268-SH | m | Gene Silencing | Puromycin | 0 | ||
Fc ε RIγ shRNA (m) レンチウイルス粒子 | sc-45268-V | m | Gene Silencing | Puromycin | 0 | ||
Fc γ RIII siRNA (m) | sc-145145 | m | Gene Silencing | N/A | 0 | ||
Fc γ RIII shRNA プラスミド (m) | sc-145145-SH | m | Gene Silencing | Puromycin | 0 | ||
Fc γ RIII shRNA (m) レンチウイルス粒子 | sc-145145-V | m | Gene Silencing | Puromycin | 0 |